#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Niemann-Pick disease Liver abscess Hereditary angioedema with C1 esterase inhibitor deficiency Hypochondroplasia Pulmonary sarcoidosis Squamous cell carcinoma of the hypopharynx Encephalopathy neonatal Phaeochromocytoma Transferrin decreased Small intestine adenocarcinoma Mucopolysaccharidosis I Immunoglobulin G4 related disease Staphylococcal infection Hypergammaglobulinaemia benign monoclonal Extra-osseous Ewing's sarcoma recurrent More trials…

    Learn about Rare Diseases

    Osteosarcoma Optic glioma – Treatment X-linked lymphoproliferative syndrome – Diagnostics Pleural mesothelioma malignant – Trials in Disease Vascular malformation – Diagnostics Rett syndrome – Diagnostics Uterine leiomyosarcoma – Basic Information Retinoblastoma – Basic Information Thrombotic thrombocytopenic purpura – Trials in Disease Alexander disease – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    AUR200 Pozelimab Gremubamab Sodium Nitroprusside Dihydrate Abemaciclib Mitotane Iobitridol Edotreotide Berzosertib Oritavancin Gns561 Selgantolimod Clofarabine Gad20-209-Fsp-A2 Teprenone IBANDRONIC ACID Donepezil Hydrochloride Tolebrutinib Paltusotine Vesleteplirsen More therapies…

    Learn about Your Condition

    Compulsive sexual behaviour Strongyloidiasis Urinary incontinence Muscle spasticity Exfoliation glaucoma K-ras gene mutation Renal cancer Deafness bilateral Iron deficiency anaemia Developmental hip dysplasia Invasive breast carcinoma Endometrial cancer stage I Ischaemic skin ulcer Tricuspid valve disease Ocular myasthenia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Congenital, Hereditary, and Neonatal Diseases and Abnormalities

  • Long-Term Safety Study of Everolimus for Patients with Tuberous Sclerosis Complex and Refractory Seizures

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Tuberous sclerosis complex
    Investigated Drugs:
    • Everolimus
    Poland

  • Study on Synovial Hypertrophy in Patients with Hemophilia A Using Efanesoctocog Alfa Prophylaxis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Factor VIII deficiency
    Investigated Drugs:
    • Efanesoctocog Alfa
    Italy Norway Spain Sweden

  • Study on the Effects of Sodium Valproate for Hearing Preservation in Patients with Wolfram Syndrome

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Wolfram syndrome
    Investigated Drugs:
    • Valproic Acid
    • Sodium Valproate
    France Spain

  • Study of anakinra safety and effectiveness given by injection under the skin in patients with cystic fibrosis

    Not recruiting

    2 1 1
    Investigated Drugs:
    • Anakinra
    Germany

  • Study on How Concizumab Works for Patients with Hemophilia A or B with Inhibitors

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Haemophilia A with anti factor VIII
    • Haemophilia B with anti factor IX
    Investigated Drugs:
    • Concizumab
    Croatia Denmark France Italy Poland Portugal +2

  • Long-term Study on the Safety and Effectiveness of Odevixibat for Patients with Alagille Syndrome

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Odevixibat
    Belgium France Germany Italy The Netherlands Poland
Previous Page
1 … 32 33 34 35 36 … 45
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!